31 results on '"Sengupta, Jay"'
Search Results
2. Ripple Frequency Determined via a Novel Algorithm Is Associated With Atrial Fibrillation Termination and Freedom From Atrial Fibrillation
3. Miocardite Aguda como Apresentação Inicial da Mutação da Desmoplaquina – Ampliando o Diagnóstico Diferencial
4. Acute Myocarditis as the Initial Presentation of Desmoplakin Mutation – Broadening the Differential Diagnosis
5. Abstract 15091: Cardiac Ct-Guided Exclusion of Left Atrial Appendage Thrombus Prior to Electrical Cardioversion for Atrial Fibrillation
6. Abstract 235: Post-shock Asystole And Inappropriate Shocks In Patients Dying Out-of-hospital While Wearing A Defibrillator
7. Impact of Atrial Fibrillation on the Outcomes after MitraClip®: A Meta-Analysis
8. SURVIVAL OF PATIENTS PACED WITH LEADLESS VERSUS CONDUCTION SYSTEM PACEMAKERS
9. TWO HEARTS OF A KIND
10. DESMOPLAKIN GENE MUTATION IS ASSOCIATED WITH MYOCARDITIS-LIKE PRESENTATION OF ARRHYTHMOGENIC CARDIOMYOPATHY
11. The Impact and Outcomes of Right Ventricular Lead Extraction in CIED-Related Tricuspid Regurgitation
12. In-Hospital and Readmission Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement
13. Acute Myocardial Infarction-Like Events in Related Patients With a Desmoplakin-Associated Arrhythmogenic Cardiomyopathy
14. TCT-195 In-Hospital and Readmission Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement
15. TIME TO FIRST SHOCK OR NO SHOCK: LONG-TERM FOLLOW-UP OF HYPERTROPHIC CARDIOMYOPATHY PATIENTS TREATED WITH AN IMPLANTABLE DEFIBRILLATOR
16. MATCHING IMPLANTABLE DEFIBRILLATOR LONGEVITY WITH PATIENT SURVIVAL: CLINICAL AND ECONOMIC SIGNIFICANCE OF NEW BATTERY TECHNOLOGIES
17. MITRAL VALVE PROLAPSE: WHEN DOES IT STOP BEING BENIGN?
18. LATE GADOLINIUM ENHANCEMENT IS ASSOCIATED WITH ADVANCED BIVENTRICULAR DYSFUNCTION IN PATIENTS WITH ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
19. TCT-534 Outcomes After Pacemaker Implantation in Patients With New-Onset Left Bundle Branch Block After Transcatheter Aortic Valve Replacement
20. PREDICTORS OF APPROPRIATE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR THERAPY IN PATIENTS WITH ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA/CARDIOMYOPATHY
21. SHORT-CIRCUITING AND OVERSENSING DUE TO INSULATION BREACHES IN A DUAL CONDUCTOR IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LEAD: IMPLICATIONS FOR PATIENT SAFETY AND MANAGEMENT
22. HIGH BATTERY IMPEDANCE IN THE PACEMAKER DEPENDENT PATIENT: EARLY RECOGNITION AND COLLABORATIVE MANAGEMENT OF INSYNC III CRT-P DEVICE FAILURES
23. AN INVESTIGATION OF THE EVOLUTION OF IMPLANTABLE CARDIAC MONITORS: A COMPARISON OF REVEAL XTTM AND REVEAL LINQTM BASED ON ACCURACY MEASUREMENTS AND PATIENT OUTCOMES POST-DEVICE IMPLANT
24. OUTCOMES OF PERIPROCEDURAL ANTICOAGULATION THERAPY WITH WARFARIN VERSUS NEW ORAL ANTICOAGULANTS IN PATIENTS UNDERGOING CARDIAC IMPLANTABLE ELECTRONIC DEVICE PLACEMENT
25. “SILENT” ATRIAL FIBRILLATION BURDEN IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
26. POST-MYOCARDIAL INFARCTION RISK STRATIFICATION OF PATIENTS AT RISK FOR SUDDEN CARDIAC ARREST BY CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING SCAR QUANTIFICATION
27. Response to Letter by May et al Regarding Article, “Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation” by Bassiouny et al.
28. Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation
29. Abstract 8680: Long Term Outcomes in Patients with Borderline Prolonged QRS Durations Following Cardiac Resynchronization Therapy
30. Abstract 15116: Safety, Fluid Reduction and Procedural Efficiency of Paroxysmal Atrial Fibrillation Ablation With Porous-Tip Contact Force Catheter.
31. Detection of Atrial Fibrillation and Atrial Flutter by Pacemaker Device Interrogation After Transcatheter Aortic Valve Replacement (TAVR): Implications for Management.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.